-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Aurinia Pharmaceuticals Inc. annual/quarterly Depreciation history and growth rate from 2018 to 2024.
- Aurinia Pharmaceuticals Inc. Depreciation for the quarter ending March 31, 2024 was $4.85M, a 576% increase year-over-year.
- Aurinia Pharmaceuticals Inc. annual Depreciation for 2024 was $600K, unchanged from 2023.
- Aurinia Pharmaceuticals Inc. annual Depreciation for 2023 was $600K, unchanged from 2022.
- Aurinia Pharmaceuticals Inc. annual Depreciation for 2022 was $600K, a 9.5% decline from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)